Philip Tsai, Chief Technology Officer at Immunome Inc. (IMNM), bought 12,300 shares at $8.42 ($104K) on 2025-03-24, disclosed to the SEC on 2025-03-25.
Open-market purchase of $104k IMNM by Chief Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |